Venous thromboembolism risk following surgery during the COVID ‐19 pandemic
Anaesthesia · 2025
DOI: 10.1111/anae.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anaesthesia, 2025. Verfasst von Andrew Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal and Liver Theme, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS T…. Hauptthemen laut MEDLINE: Venous Thromboembolism, COVID-19, Postoperative Complications, Surgical Procedures, Operative. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Introduction
SARS‐CoV‐2 infection is associated with an increased risk of venous thromboembolism. Data are lacking on how this risk altered during the COVID‐19 pandemic and following vaccination. We aimed to evaluate the 90‐day risk of postoperative venous thromboembolism during the pandemic.
Methods
We performed a retrospective cohort study of patients having abdominal, obstetric, orthopaedic, cardiac, thoracic or vascular surgical procedures using the OpenSAFELY‐TPP platform. Crude 90‐day risks of venous thromboembolism were calculated and crude and adjusted hazard ratios were derived from individual Cox proportional hazards models.
Results
In total, 1,800,540 procedures were performed with 15,390 individual venous thromboembolic events recorded within 90 days. The highest crude absolute risk was in the Alpha wave at 1.2%. Postoperative SARS‐CoV‐2 infection was associated with a 4.4‐fold increase in relative risk of 90‐day venous thromboembolism (adjusted hazard ratio 4.42, 95%CI 4.21–4.64) compared with those without. Recent SARS‐CoV‐2 infection was associated with an increased risk of venous thromboembolism (adjusted hazard ratio 4.03, 95%CI 3.78–4.30) compared with those without. Patients who were unvaccinated had the highest relative risk for 90‐day venous thromboembolism. A single dose of vaccine was associated with a 20% relative risk reduction of venous thromboembolism (adjusted hazard ratio 0.80, 95%CI 0.76–0.84).
Discussion
SARS‐CoV‐2 infection status and vaccination history were associated with 90‐day venous thromboembolism risk, with both recent and postoperative SARS‐CoV‐2 infection associated with an increased risk, whilst one dose of vaccine reduced the risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal and Liver Theme, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- University of Nottingham, School of Medicine, Queen's Medical Centre, Nottingham, UK.
- Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
- Lifespan and Population Health, University of Nottingham, School of Medicine, Nottingham, UK.
ORCID-Profile: David J Humes, Amir Mehrkar, Ben Goldacre, Joe West, Colin J Crooks
Zitieren
APA
Jackson, A., Humes, D. J., Mehrkar, A., Bacon, S. C. J., Davy, S., Goldacre, B., West, J., & Crooks, C. J. (2025). Venous thromboembolism risk following surgery during the COVID ‐19 pandemic. Anaesthesia. https://doi.org/10.1111/anae.70091
Vancouver
Jackson A, Humes DJ, Mehrkar A, Bacon SCJ, Davy S, Goldacre B, et al. Venous thromboembolism risk following surgery during the COVID ‐19 pandemic. Anaesthesia. 2025. doi:10.1111/anae.70091
BibTeX
@article{Jackson2025,
author = {Jackson, Andrew and Humes, David J and Mehrkar, Amir and Bacon, Sebastian C J and Davy, Simon and Goldacre, Ben and West, Joe and Crooks, Colin J},
title = {Venous thromboembolism risk following surgery during the COVID ‐19 pandemic},
journal = {Anaesthesia},
year = {2025},
doi = {10.1111/anae.70091}
}
EUVIMED